Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
16
NCT07014059
Autologous Serum Obtained by a Closed-Circuit Collection Device
Phase: Phase 2
Role: Collaborator
Start: Jun 20, 2025
Completion: Jun 20, 2027